These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 176171)

  • 21. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free cortisol/cortisone ratio in pooled urine was increased after rapid-ACTH stimulation test under dexamethasone suppression.
    Koyama Y; Homma K; Murata M; Shibata H; Itoh H; Hasegawa T
    Endocr J; 2011; 58(12):1099-103. PubMed ID: 22008388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of cortisol inactivation in cirrhosis of the liver.
    Vogeser M; Fischer G; Jacob K
    Exp Clin Endocrinol Diabetes; 1998; 106(5):410-4. PubMed ID: 9831307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
    Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
    Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Individual glucocorticoid composition in free glucoronide and sulphate urine fractions in Itsenko-Cushing disease].
    Naryzhniuk ND
    Probl Endokrinol (Mosk); 1968; 14(1):5-8. PubMed ID: 5736999
    [No Abstract]   [Full Text] [Related]  

  • 35. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK; Peters TJ; Taylor NF; Wood PJ; Wessely S; Cleare AJ
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands.
    van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3750-7. PubMed ID: 8530629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF.
    Otokida K; Fujiwara T; Oriso S; Kato M
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):651-6. PubMed ID: 2795994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on steroid conjugates. VI. Quantitative paper chromatography of urinary corticosteroids in essential hypertension.
    Kornel L; Starnes WR; Hill A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1608-17. PubMed ID: 5347690
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing's syndrome.
    Djedovic NK; Rainbow SJ
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):542-9. PubMed ID: 21846739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.